Robert P. Bresnahan, Jr. sold Incyte Corporation (NASDAQ: INCY)
Robert P. Bresnahan, Jr. (R-PA), a U.S. Representative, has disclosed 1 trade in Incyte Corporation (INCY) since 2025, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Robert P. Bresnahan, Jr. sold $1,001 - $15,000 of Incyte Corporation (NASDAQ: INCY) on May 15, 2025. Since that trade, INCY is up +95.97% against the S&P 500 up +27.05%, an outperformance of +68.91%.
Data updated
Robert P. Bresnahan, Jr.'s INCY trades vs the price
INCY is up +95.97% since Robert P. Bresnahan, Jr. sold on May 15, 2025, versus +27.05% for the S&P 500.
Performance since this trade
All Robert P. Bresnahan, Jr. INCY trades
Robert P. Bresnahan, Jr. & INCY trading FAQ
Is it legal for Robert P. Bresnahan, Jr. to trade Incyte Corporation (INCY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Incyte Corporation (INCY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Robert P. Bresnahan, Jr. sell INCY?
Robert P. Bresnahan, Jr. disclosed a sale of $1,001 - $15,000 of Incyte Corporation (INCY) on May 15, 2025, according to public STOCK Act filings.
How has INCY performed since Robert P. Bresnahan, Jr.'s trade?
Since Robert P. Bresnahan, Jr. sold INCY on May 15, 2025, the stock is up +95.97%, versus +27.05% for the S&P 500 over the same period, an outperformance of +68.91%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional INCY trades?
Quantellect tracks every disclosed congressional trade in Incyte Corporation (INCY) on the Incyte Corporation congressional trading page, which aggregates filings across all members of Congress.
Robert P. Bresnahan, Jr.'s INCY tradesAll congressional filings for Incyte CorporationRobert P. Bresnahan, Jr.'s full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.